Bogaert Jan, Kalantzi Maria, Rademakers Frank E, Dymarkowski Steven, Janssens Stefan
Department of Radiology, Gasthuisberg University Hospital, Herestraat 49, 3000, Leuven, Belgium.
Eur Radiol. 2007 Oct;17(10):2572-80. doi: 10.1007/s00330-007-0627-9. Epub 2007 Mar 15.
Microvascular obstruction (MVO) is an important and independent determinant of post-infarct remodeling. Fifty-two patients with a successfully reperfused ST-segment elevation acute myocardial infarction (MI) were studied with MRI in the first week and at 4 months post-infarction. On early (i.e., 2-5 min) post-contrast MRI, MVO was detected in 32 patients with an MVO to infarct ratio of 36.3 +/- 24.9%. On late (i.e., 10-25 min) post-contrast MRI, MVO was detected in only 27 patients, with an MVO to infarct ratio of 15.9 +/- 13.9%. MVO infarcts (n = 32) were associated with higher cardiac enzymes (troponin I, P = 0.016), and lower pre-revascularization thrombolysis in myocardial infarction (TIMI) flow (P = 0.018) than non-MVO infarcts (n = 20). Infarct size was larger in MVO infarcts (25.0 +/- 14.3 g) than non-MVO infarcts (12.5 +/- 7.9 g), P = 0.0007. Systolic wall thickening in the infarct and peri-infarct area, and left ventricular (LV) ejection fraction (EF) were worse in MVO (46.1 +/- 7.2%) than non-MVO infarcts (50.5 +/- 6.6%, P = 0.038). At 4 months, MVO infarcts showed more adverse remodeling and lack of functional improvement, whereas non-MVO infarcts improved significantly (LV EF at 4 months, MVO, 47.5 +/- 7.8%, P = 0.31; non-MVO, 55.2 +/- 10.3%, P = 0.0028). In the majority of patients with successfully reperfused ST-segment elevation MI, MVO is observed, whose present and maximal extent can be best evaluated on early post-contrast MRI. Presence of MVO is associated with more extensive infarctions, and characterized by greater adverse LV remodeling and lack of functional recovery.
微血管阻塞(MVO)是梗死后期重塑的一个重要且独立的决定因素。对52例成功再灌注的ST段抬高型急性心肌梗死(MI)患者在梗死第一周及4个月时进行了MRI研究。在造影剂注射后早期(即2 - 5分钟)的MRI检查中,32例患者检测到MVO,MVO与梗死面积的比例为36.3±24.9%。在造影剂注射后晚期(即10 - 25分钟)的MRI检查中,仅27例患者检测到MVO,MVO与梗死面积的比例为15.9±13.9%。与非MVO梗死(n = 20)相比,MVO梗死(n = 32)患者的心肌酶(肌钙蛋白I,P = 0.016)更高,再灌注前心肌梗死溶栓(TIMI)血流更低(P = 0.018)。MVO梗死的梗死面积(25.0±14.3 g)大于非MVO梗死(12.5±7.9 g),P = 0.0007。MVO梗死患者梗死区及梗死周边区域的收缩期壁增厚以及左心室(LV)射血分数(EF)(46.1±7.2%)比非MVO梗死患者(50.5±6.6%,P = 0.038)更差。在4个月时,MVO梗死显示出更多的不良重塑且功能改善不足,而非MVO梗死则有显著改善(4个月时LV EF,MVO为47.5±7.8%,P = 0.31;非MVO为55.2±10.3%,P = 0.0028)。在大多数成功再灌注的ST段抬高型MI患者中可观察到MVO,其当前及最大范围在造影剂注射后早期MRI上能得到最佳评估。MVO的存在与更广泛的梗死相关,其特征为更严重的左心室不良重塑和功能恢复不足。